Total Positions
131
Quarter
2025 Q4
Top Holding
PRAX (10.5%)
Top 10 Concentration
41.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 131
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 10.49% | 2.39% |
#1
12
Prev: #13
|
6.3 | 431,432 | 27.6% |
P
S
|
1,995,986 | $588,296,914 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.62% | 4.22% |
#2
2
Prev: #4
|
4.3 | 203,881 | 6.9% |
P
S
|
3,160,200 | $315,198,348 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 4.86% | 8.33% |
#3
2
Prev: #1
|
2.2 | -416,558,578 | -99.4% |
P
S
|
2,546,391 | $272,565,693 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 4.11% | 6.25% |
#4
2
Prev: #2
|
1.6 | -7,080 | -0.7% |
P
S
|
1,081,421 | $230,602,214 | 2015 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 3.14% | 1.55% |
#5
18
Prev: #23
|
3.5 | 978,662 | 72.4% |
P
S
|
2,330,651 | $175,917,537 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 3.09% | 3.22% |
#6
2
Prev: #8
|
3.3 | 617,000 | 8.4% |
P
S
|
7,985,461 | $173,284,504 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 2.99% | 3.90% |
#7
2
Prev: #5
|
3.2 | 102,769 | 6.6% |
P
S
|
1,665,105 | $167,492,912 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.91% | 2.62% |
#8
3
Prev: #11
|
3.2 | 483,565 | 12.7% |
P
S
|
4,278,180 | $163,469,258 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 2.39% | — |
#9
Prev: #—
|
3.0 | 1,100,000 | no change |
NEW
|
1,100,000 | $134,123,000 | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 2.17% | 0.74% |
#10
29
Prev: #39
|
3.2 | 735,000 | 157.9% |
P
S
|
1,200,487 | $121,921,460 | 2010 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 2.10% | 1.98% |
#11
6
Prev: #17
|
2.9 | 320,291 | 31.1% |
P
S
|
1,350,425 | $117,946,120 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.05% | 1.29% |
#12
15
Prev: #27
|
2.8 | 125,000 | 9.4% |
P
S
|
1,452,707 | $114,763,853 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.97% | 1.78% |
#13
6
Prev: #19
|
2.8 | 662,080 | 17.4% |
P
S
|
4,457,974 | $110,624,625 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 1.94% | 2.31% |
#14
Prev: #14
|
2.8 | 1,000,000 | 10.7% |
P
S
|
10,383,456 | $109,026,288 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.79% | 0.60% |
#15
30
Prev: #45
|
3.0 | 1,839,780 | 149.6% |
P
S
|
3,069,225 | $100,547,811 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 1.78% | 3.51% |
#16
9
Prev: #7
|
0.7 | -667,483 | -7.5% |
P
S
|
8,284,882 | $100,081,375 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
ARCELLX INC
|
Healthcare | 1.70% | 5.85% |
#17
14
Prev: #3
|
0.8 | -1,002,282 | -40.6% |
P
S
|
1,466,071 | $95,587,829 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.69% | 0.91% |
#18
15
Prev: #33
|
3.0 | 1,580,303 | 108.1% |
P
S
|
3,042,703 | $94,688,917 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.66% | 0.87% |
#19
16
Prev: #35
|
3.0 | 669,000 | 215.8% |
P
S
|
979,000 | $93,347,650 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 1.62% | 1.45% |
#20
5
Prev: #25
|
0.6 | no change | no change |
P
S
|
6,370,851 | $90,720,918 | 2007 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 1.53% | 1.03% |
#21
8
Prev: #29
|
2.8 | 1,171,187 | 56.0% |
P
S
|
3,261,850 | $85,884,511 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATXS
ASTRIA THERAPEU...
|
Healthcare | 1.51% | 1.36% |
#22
4
Prev: #26
|
0.6 | no change | no change |
P
S
|
6,485,420 | $84,894,147 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 1.46% | 3.00% |
#23
14
Prev: #9
|
0.6 | -2,300,000 | -18.2% |
P
S
|
10,326,103 | $82,092,519 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AORT
ARTIVION INC
|
Healthcare | 1.40% | 2.47% |
#24
12
Prev: #12
|
0.6 | -297,710 | -14.7% |
P
S
|
1,722,290 | $78,553,647 | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 1.30% | 2.17% |
#25
10
Prev: #15
|
0.5 | -183,268 | -5.9% |
P
S
|
2,917,634 | $72,970,026 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 3.68% |
Sold All 😨
(Was: #6) |
0.3 | -1,353,093 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 2.92% |
Sold All 😨
(Was: #10) |
0.3 | -702,130 | -100.0% |
CLOSED
|
— | $— | 2014 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRNA
VERONA PHARMA P...
|
Unknown | 0.00% | 1.61% |
Sold All 😨
(Was: #20) |
0.3 | -524,088 | -100.0% |
CLOSED
|
— | $— | 2017 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 1.56% |
Sold All 😨
(Was: #22) |
0.3 | -1,135,766 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 0.00% | 0.21% |
Sold All 😨
(Was: #65) |
0.3 | -292,686 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 0.00% | 0.20% |
Sold All 😨
(Was: #67) |
0.3 | -85,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HTFL
HEARTFLOW INC
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #72) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SCPH
SCPHARMACEUTICA...
|
Unknown | 0.00% | 0.10% |
Sold All 😨
(Was: #76) |
0.3 | -583,142 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #77) |
0.3 | -105,597 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #78) |
0.3 | -1,178,307 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRY
PUT
ARS PHARMACEUTI...
|
PUT Option | 0.00% | 0.06% |
Sold All 😨
(Was: #80) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRIB
TRINITY BIOTECH...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #81) |
0.3 | -1,790,000 | -100.0% |
CLOSED
|
— | $— | 2008 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYRA
LYRA THERAPEUTI...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #84) |
0.3 | -229,382 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #85) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2014 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APYX
APYX MEDICAL CO...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #89) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 131 holdings